We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA’s advertising division has cited ISTA Pharmaceuticals for running a misleading journal ad that fails to disclose risks associated with its spreading agent Vitrase.
Saying PhRMA’s voluntary code of conduct doesn’t go far enough, AstraZeneca has proposed that drugmakers submit to mandatory FDA review of all direct-to-consumer (DTC) advertisements prior to use.
Pharmaceutical companies are ready to legally challenge any efforts to eliminate direct-to-consumer (DTC) advertising, industry officials said during an FDA public hearing last week on DTC activities.
Pharmaceutical companies are ready to legally challenge any efforts to eliminate direct-to-consumer (DTC) advertising, industry officials said during the first day of a two-day FDA public hearing on DTC activities. Agency officials responded that they will not seek to prohibit DTC ads, but are considering new ways to regulate the practice.
Saying PhRMA's voluntary code of conduct doesn't go far enough, AstraZeneca has proposed that drugmakers submit to mandatory FDA review of all direct-to-consumer (DTC) advertisements prior to use.
The Medicare Modernization Act’s (MMA) requirement that the president notify Congress of rising Medicare expenses and introduce fast-track legislation to contain spending will likely force lawmakers to limit direct-to-consumer (DTC) marketing, consumer advocates say, citing the high cost of advertising and its effect on overall drug spending.
More than 80 percent of physicians believe a moratorium should be placed on direct-to-consumer (DTC) advertising immediately following the approval of a new drug, according to a survey conducted by HRA Research.
Two House lawmakers have introduced legislation that would impose limitations on direct-to-consumer (DTC) advertising for drugs, including the establishment of a moratorium on DTC activities immediately following FDA approval of a new drug.
More than 80 percent of physicians believe a moratorium should be placed on direct-to-consumer (DTC) advertising immediately following the approval of a new drug, according to a survey conducted by HRA Research.
Pfizer’s promotional strategy for Lipitor, the world’s top-selling drug, targeted patient populations that had not been covered in clinical trials of the cholesterol-lowering treatment, resulting in billions of dollars in unnecessary drug spending, alleges a class-action lawsuit filed by consumer groups.